SMALL RNA AS ANTIAGING COSMECEUTICALS 465 (5) T.C. Tsai, B.S. Hantash, and B.M. Hantash, Cosmeceutical Agents: A comprehensive review of the literature clinical medicine, Dermatology, 1, 1–20 (2008). (6) C.K. Huang, and T.A. Miller, The truth about over-the-counter topical anti-aging products: A com- prehensive review, Aesthet. Surg. J., 27(4), 402–412 (2007). (7) B. Geusens, N. Sanders, T. Prow, M. Van Gele, and J. Lambert, Cutaneous short-interfering RNA therapy, Expert Opin. Drug Deliv., 6(12), 1333–1349 (2009). (8) G. Jenkins, Molecular mechanisms of skin ageing, Mech. Ageing Dev., 123(7), 801–810 (2002). (9) R.M. Lavker, P.S Zheng, and G Dong, Aged skin: A study by light, transmission electron, and scan- ning electron microscopy, J. Invest. Dermatol., 88(3 Suppl), 44–51(1987). (10) P.K. Mukherjee, N. Maity, N.K. Nema, and B.K. Sarkar, Bioactive compounds from natural resources against skin aging, Phytomedicine, 19(1), 64–73 (2011). (11) M.A. Farage, K.W. Miller, and H.I. Maibach, “Degenerative Changes in Aging Skin” in Textbook of Aging Skin, M.A. Farage, K.W. Miller and H.I. Maibach. Eds. (Springer-Verlag, Berlin, Heidelberg, 2010), pp.25–35. (12) R.M. Trüeb, and D.J. Tobin, Aging Hair (Springer-Verlag Berlin Heidelberg, 2010), pp. v–vi. (13) S. Harrison, and R Sinclair, Hair colouring, permanent styling and hair structure, J. Cosmet. Dermatol., 2, 180–185 (2004). (14) R.M Trüeb, Oxidative stress in ageing of hair, Int. J. Trichology, 1(1), 6–14 (2009). (15) A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello, Potent and specifi c ge- netic interference by double-stranded RNA in Caenorhabditis elegans, Nature, 391, 806–811 (1998). (16) B.K. Sun, and H.Tsao, Small RNAs in development and disease, J. Am. Acad. Dermatol., 59(5), 725– 737 (2008). (17) L. He, and G.J. Hannon, MicroRNAs: Small RNAs with a big role in gene regulation, Nat. Rev. Genet., 5(7), 522–531 (2004). (18) J.C. Burnett, J.J. Rossi, and K. Tiemann, Current progress of siRNA/shRNA therapeutics in clinical trials, Biotechnol. J., 6(9), 1130–1146 (2011). (19) M.K. Robinson, R.L. Binder, and C.E. Griffi ths, Genomic-driven insights into changes in aging skin, J. Drugs Dermatol., 8(7 Sup), s8–11(2009). (20) J.A. McGrath, M.K. Robinson, and R.L. Binder, Skin differences based on age and chronicity of ultra- violet exposure: Results from a gene expression profi ling study, Br. J. Dermatol., 166(Sup 2), 9–15 (2012). (21) W.R. Swindell, A. Johnston, L. Sun, X. Xing, G.J. Fisher, M.L. Bulyk, J.T. Elder, and J.E. Gudjonsson, Meta-profi les of gene expression during aging: Limited similarities between mouse and human and an unexpectedly decreased infl ammatory signature, PLoS One., 7(3), e33204(2012). (22) D.T. Wu, J.S. Chen, D.C. Chang, and S.L. Lin, Mir-434-5p mediates skin whitening and lightening, Clin. Cosmet. Investig. Dermatol., 1, 19–35 (2008). (23) J.S. Chen, and D.T. Wu, Application of intronic microRNA agents in cosmetics. Methods Mol. Bio., 936, 325–341 (2013). (24) C.D. Christine, and T.S. Jean, United States Patent Application 2009/0081263. (25) X. Yi, G. Zhao, H. Zhang, D. Guan, R. Meng, Y. Zhang, Q. Yang, H. Jia, K. Dou, C. Liu, F. Que, and J.Q. Yin, MITF-siRNA formulation is a safe and effective therapy for human melasma, Mol. Ther., 19(2), 362–371 (2011). (26) G. Zhao, Q. Yin, R. Meng, Q. Yang, H. Jia and H. Zhang, Clinical effi cacy and safety observation of topical 0.5% MITF-siRNA cream on melasma. The Chin. J. Dermatovenereol., 24(8), 692–695 (2010). (27) Khusial, R.S Permanan, L. Uma, and W. John, United States Patent Application 2012/0165373 A1. (28) E. Olson, and E.V. Rooij, United States Patent application 2010/0285073 A1. (29) A. Dugour, K. Hagelin, C. Smus, M.E. Balañá, and N. Kerner, Silencing the androgen receptor: New skills for antiandrogen oligonucleotide skin and hair therapy, J. Dermatol. Sci., 54(2), 123–125 (2009). (30) M.E. Balañá, C. Alvarez Roger, A.V. Dugour, and N.A. Kerner, Antiandrogen oligonucleotides: Ac- tive principles in hair- and skin derived culture cells, J. Drugs Dermatol., 3(3), 287–294 (2004). (31) M. Nakamura, J. Jo, Y. Tabata, and O. Ishikawa, Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model, Am. J. Pathol., 172(3), 650–658 (2008). (32) A.N. Mardaryev, M.I. Ahmed, N.V. Vlahov, M.Y. Fessing, J.H. Gill, A.A. Sharov, and N.V. Botchkareva, Micro-RNA-31 controls hair cycle-associated changes in gene expression programs of the skin and hair follicle, FASEB J., 24(10), 3869–3881 (2010).

JOURNAL OF COSMETIC SCIENCE 466 (33) S.L. Lin, D. Chang, and C.H. Lin, Regulation of somatic cell reprogramming through inducible mir- 302 expression, Nucleic Acids Res., 39, 1054–1065 (2011). (34) E.S. Lee, J.H. Kim, S. Im, K.B. Lee, S. Sohn, and W.H. Kang, Application of computerized image analysis in pigmentary skin diseases, Int. J. Dermatol., 40(1), 45–49(2001). (35) K. Tief, M. Hahne, A. Schmidt, and F. Beermann, Tyrosinase, the key enzyme in melanin synthesis, is expressed in murine brain, Eur. J. Biochem., 241(1), 12–16 (1996). (36) E. Steingrímsson, N.G. Copel, and N.A. Jenkins, Melanocytes and the microphthalmia transcription factor network, Annu. Rev. Genet., 38, 365–411 (2004). (37) M. Tassabehji, V.E. Newton, and A.P. Read, Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene, Nat. Genet., 8(3), 251–255 (1994). (38) X.H. Gao, L. Zhang, H. Wei, and H.D. Chen, Effi cacy and safety of innovative cosmeceuticals, Clin. Dermatol., 26(4), 367–374 (2008). (39) A.J. Miller, and M.C. Jr. Mihm, Melanoma, N. Engl. J. Med., 355(1), 51–65 (2006). (40) T.J. Hemesath, E. Steingrímsson, G. McGill, M.J. Hansen, J. Vaught, C.A. Hodgkinson, H. Arnheiter, N.G. Copeland, N.A. Jenkins, and D.E. Fisher, Microphthalmia, a critical factor in melanocyte devel- opment, defi nes a discrete transcription factor family, Genes. Dev., 8(22), 2770–2780 (1994). (41) R. Kamakshi, Fairness via formulations: A review of cosmetic skin-lightening ingredients. J Cosmet Sci, 63(1), 43–54 (2012). (42) D. Murase, A. Hachiya, Y. Amano, A. Ohuchi, T. Kitahara, and Y. Takema, The essential role of p53 in hyperpigmentation of the skin via regulation of paracrine melanogenic cytokine receptor signaling, J. Biol. Chem., 284(7), 4343–4353 (2009). (43) G.E. Piérard, I. Uhoda, and C. Piérard-Franchimont, From skin microrelief to wrinkles. An area ripe for investigation, J. Cosmet. Dermatol., 2(1), 21–28 (2003). (44) R.G. Glogau, Chemical peeling and aging skin, J Geriatr. Dermatol., 2(1), 5–10 (1994). (45) J. Krutmann, How the sun ages our skin, the dermis as the driving force, Der Hautarzt, 62(8), 588– 590 (2011). (46) P. Schroeder, T. Gremmel, M. Berneburg, and J. Krutmann, Partial depletion of mitochondrial DNA from human skin fi broblasts induces a gene expression profi le reminiscent of photoaged skin, J. Invest. Dermatol., 128(9), 2297–2303 (2008). (47) M. Majora, T. Wittkampf, B. Schuermann, M. Schneider, S. Franke, S. Grether-Beck, E. Wilichowski, F. Berner, P. Schroeder, and J. Krutmann, Functional consequences of mitochondrial DNA deletions in human skin fi broblasts: Increased contractile strength in collagen lattices is due to oxidative stress- induced lysyl oxidase activity, Am. J. Pathol., 175(3), 1019–1029 (2009). (48) N. Kaneko, A. Vierkoetter, U. Kraemer, D. Sugiri, M. Matsui, A. Yamamoto, J. Krutmann, and A. Morita, Mitochondrial common deletion mutation and extrinsic skin ageing in German and Japanese women, Exp. Dermatol., 21(Suppl 1), 26–30 (2012). (49) N. Philips, S Auler, R. Hugo, and S. Gonzalez, Benefi cial regulation of matrix metalloproteinases for skin health, Enzyme Res., 427285 (2011). (50) L Baumann, Cosmetic Dermatology: Principles and Practice (The McGraw-Hill Companies Medical, Boston, MA, 2002), pp. 29. (51) D. Xu, and H. Tahara, The role of exosomes and microRNAs in senescence and aging, Adv. Drug Deliv. Rev., 65(3):368–375 (2013). (52) M. Takahashi, A. Eda, T. Fukushima, and H. Hohjoh, Reduction of type IV collagen by up-regulated miR-29 in normal elderly mouse and klotho-defi cient, senescence-model mouse, PLoS One, 7(11), e48974 (2012). (53) D.J. Bates, N. Li, R. Liang, H. Sarojini, J. An, M.M. Masternak, A. Bartke, and E. Wang, MicroRNA regulation in Ames dwarf mouse liver may contribute to delayed aging, Aging Cell, 9(1), 1–18 (2010). (54) A.P. Ugalde, A.J. Ramsay, J. Rosa, I. Varela, G. Mariño, J. Cadiñanos, J. Lu, J.M. Freije, and C. López- Otín, Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53, EMBO J., 30(11), 2219–2232 (2011). (55) S.Y. Park, J.H. Lee, M. Ha, J.W. Nam, and V.N. Kim, MiR-29 miRNAs activate p53 by targeting p85 alpha and CDC42, Nat. Struct. Mol. Biol., 16(1), 23–29 (2009). (56) R. Francis, C. Judith, and B. Dipa, Two faces of p53: aging and tumor suppression, Nucleic Acids Res., 35(22), 7475–7484 (2007). (57) S.D. Tyner, S. Venkatachalam, J. Choi, S. Jones, N. Ghebranious, H. Igelmann, X. Lu, G. Soron, B. Cooper, C. Brayton, S.H. Park, T. Thompson, G. Karsenty, A. Bradley, and L.A. Donehower, P53 mutant mice that display early ageing-associated phenotypes, Nature, 415(6867), 45–53 (2002).